← Back to Patent Explorer
US4537859A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for preparing 3-hydroxy-ML-236B derivatives known as M-4 and M-4'

Assignee: Sankyo Co Ltd
•
Filing: 1982-11-18
•
Granted: 1985-08-27
•
Expires: 2002-11-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of formula (I): ##STR1## (wherein OH represents OH or OH), that is to say M-4 carboxylic acid and M-4' carboxylic acid, as well as pharmaceutically acceptable salts and esters thereof and the corresponding ring-closed lactones may be prepared by contacting an ML-236B compound with a microorganism of the genus Nocardia or a cell-free, enzyme-containing extract thereof and then, if necessary, subjecting the resulting product to one or more of the following reactions: hydrolysis, salification, esterification and lactonisation. The resulting M-4 and M-4' derivatives have the ability to inhibit the biosynthesis of cholesterol and are therefore of value in the therapy and/or prophylaxis of hyperlipaemia and arteriosclerosis.

Inventors

  • 👤 Akira Terahara
  • 👤 Minoru Tanaka

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:15
CPC Classifications
C; C12; C12P; C12P7/00; C12P7/40; C12P7/42; A; A61; A61P; A61P9/00; A61P9/10; C12N; C12N1/00; C12N1/20; C12N1/205; C12P17/00; C12P17/02; C12P17/06; C12P7/62; C12R; C12R2001/00; C12R2001/01; C12R2001/365; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822; Y10S435/872

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 74 words
A process for preparing a compound of formula (I): ##STR7## wherein OH represents OH or OH, pharmaceutically acceptable salts and esters thereof and the corresponding ring-closed lactones, which process comprises contacting an ML-236B compound selected from the group consisting of ML-236B carboxyic acid, salts and esters thereof and the corresponding ML-236B lactone with a hydroxylation enzyme produced by a microorganism of the genus Nocardia to produce the hydroxylated ML-236B compound of the formula (I).
Claim 2
Dependent Claim 74 words
A process for preparing a compound of formula (I): ##STR7## wherein OH represents OH or OH, pharmaceutically acceptable salts and esters thereof and the corresponding ring-closed lactones, which process comprises contacting an ML-236B compound selected from the group consisting of ML-236B carboxyic acid, salts and esters thereof and the corresponding ML-236B lactone with a hydroxylation enzyme produced by a microorganism of the genus Nocardia to produce the hydroxylated ML-236B compound of the formula (I).
Claim 3
Dependent Claim 31 words
A process as claimed in claim 1, wherein said ML-236B compound is contacted with said enzyme by cultivating a microorganism of the genus Nocardia in a medium containing said ML-236B compound.
Claim 4
Dependent Claim 28 words
A process as claimed in claim 2, wherein said microorganism is a species selected from the group consisting of Nocardia autotrophica, Nocardia asteroides, Nocardia farcinica and Nocardia coeliaca.
Claim 5
Dependent Claim 50 words
A process as claimed in claim 2, wherein said microorganism is selected from the group consisting of: Nocardia autotrophica FERM P-6181 Nocardia autotrophica subsp. canberrica FERM P-6182 Nocardia autotrophica subsp. amethystina FERM P-6183 Nocardia autotrophica IFO 12743 Nocardia asteroides IFO 3424 Nocardia farcinica ATCC 3318 and Nocardia coeliaca ATCC 17040.
Claim 6
Dependent Claim 41 words
A process as claimed in claim 2, wherein said microorganism is selected from the group consisting of: Nocardia autotrophica FERM P-6181 Nocardia autotrophica subsp. canberrica FERM P-6182 Nocardia autotrophica subsp. amethystina FERM P-6183 Nocardia autotrophica IFO 12743 Nocardia asteroides IFO 3424.
Claim 7
Dependent Claim 34 words
A process as claimed in claim 2, wherein said microorganism is selected from the group consisting of: Nocardia autotrophica FERM P-6181 Nocardia autotrophica subsp. canberrica FERM P-6182 and Nocardia autotrophica subsp. amethystina FERM P-6183.
Claim 8
Dependent Claim 31 words
A process as claimed in claim 1, wherein said ML-236B compound is contacted with said enzyme by contacting whole cells of a microorganism of the genus Nocardia with said ML-236B compound.
Claim 9
Dependent Claim 28 words
A process as claimed in claim 7, wherein said microorganism is a species selected from the group consisting of Nocardia autotrophica, Nocardia asteroides, Nocardia farcinica and Nocardia coeliaca.
Claim 10
Dependent Claim 50 words
A process as claimed in claim 7, wherein said microorganism is selected from the group consisting of: Nocardia autotrophica FERM P-6181 Nocardia autotropica subsp. canberrica FERM P-6182 Nocardia autotrophica subsp. amethystina FERM P-6183 Nocardia autotrophica IFO 12743 Nocardia asteroides IFO 3424 Nocardia farcinica ATCC 3318 and Nocardia coeliaca ATCC 17040.
Claim 11
Dependent Claim 41 words
A process as claimed in claim 7, wherein said microorganism is selected from the group consisting of: Nocardia autotrophica FERM P-6181 Nocardia autotrophica subsp. canberrica FERM P-6182 Nocardia autotrophica subsp. amethystina FERM P-6183 Nocardia autotrophica IFO 12743 Nocardia asteroides IFO 3424.
Claim 12
Dependent Claim 34 words
A process as claimed in claim 7, wherein said microorganism is selected from the group consisting of: Nocardia autotrophica FERM P-6181 Nocardia autotrophica subsp. canberrica FERM P-6182 and Nocardia autotrophica subsp. amethystina FERM P-6183.
Claim 13
Dependent Claim 32 words
A process as claimed in claim 1, wherein said ML-236B compound is contacted with said enzyme by contacting said compound with a cell-free, enzyme-containing extract of a microorganism of the genus Nocardia.
Claim 14
Dependent Claim 28 words
A process as claimed in claim 12, wherein said microorganism is a species selected from the group consisting of Nocardia autotrophica, Nocardia asteroides, Nocardia farcinica and Nocardia coeliaca.
Claim 15
Dependent Claim 50 words
A process as claimed in claim 12, wherein said microorganism is selected from the group consisting of: Nocardia autotrophica FERM P-6181 Nocardia autotrophica subsp. canberrica FERM P-6182 Nocardia autotrophica subsp. amethystina FERM P-6183 Nocardia autotrophica IFO 12743 Nocardia asteroides IFO 3424 Nocardia farcinica ATCC 3318 and Nocardia coeliaca ATCC 17040.
Claim 16
Dependent Claim 41 words
A process as claimed in claim 12, wherein said microorganism is selected from the group consisting of: Nocardia autotrophica FERM P-6181 Nocardia autotrophica subsp. canberrica FERM P-6182 Nocardia autotrophica subsp. amethystina FERM P-6183 Nocardia autotrophica IFO 12743 Nocardia asteroides IFO 3424.
Claim 17
Dependent Claim 34 words
A process as claimed in claim 12, wherein said microorganism is selected from the group consisting of: Nocardia autotrophica FERM P-6181 Nocardia autotrophica subsp. canberrica FERM P-6182 and Nocardia autotrophica subsp. amethystina FERM P-6183.
Claim 18
Dependent Claim 34 words
A process as claimed in claim 1, wherein said microorganism is selected from the group consisting of Nocardia autotrophica FERM P-6181, Nocardia autotrophica subsp. canberrica FERM P-6182 and Nocardia autotrophica subsp. amethystina FERM P-6183.
Claim 19
Dependent Claim 19 words
A process as claimed in claim 1, wherein there is produced an M-4 compound in which OH represents OH.
Claim 20
Dependent Claim 19 words
A process as claimed in claim 17, wherein there is produced an M-4 compound in which OH represents OH.
Claim 21
Dependent Claim 19 words
A process as claimed in claim 1, wherein there is produced an M-4' compound in which OH represents OH.
Claim 22
Dependent Claim 19 words
A process as claimed in claim 17, wherein there is produced an M-4' compound in which OH represents OH.
Claim 23
Dependent Claim 20 words
A process as claimed in claim 1, wherein there is produced the sodium salt of said compound of formula (I).

References Cited (Backward Citations)

US3281330A Cited
US3392171A Cited
US4410629A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-08-26 1989-02-25 1989-08-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-08-26 1993-02-25 1993-08-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-08-26 1997-02-25 1997-08-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag